CHRD (NASDAQ: CHRD) insider files to sell 8,000 common shares
Rhea-AI Filing Summary
Douglas Brooks filed a notice to sell up to 8,000 shares of CHRD common stock through Fidelity Brokerage Services, with an aggregate market value of $1,065,125.60 as of August 7, 2026 on NASDAQ. The shares trace to multiple restricted stock vesting awards between November 2020 and April 2026.
Brooks also reports recent sales of CHRD common stock: 3,000 shares on May 7, 2026 for $413,378.95, 3,500 shares on May 8, 2026 for $478,482.50, and 1,500 shares on May 11, 2026 for $207,855.15.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 8,000 shares
Aggregate market value of planned sale: $1,065,125.60
Sale on 05/07/2026: 3,000 shares for $413,378.95
+4 more
7 metrics
Planned shares to be sold
8,000 shares
CHRD common stock under Form 144
Aggregate market value of planned sale
$1,065,125.60
Value of 8,000 CHRD shares as of 08/07/2026 on NASDAQ
Sale on 05/07/2026
3,000 shares for $413,378.95
CHRD common stock sold by Douglas Brooks
Sale on 05/08/2026
3,500 shares for $478,482.50
CHRD common stock sold by Douglas Brooks
Sale on 05/11/2026
1,500 shares for $207,855.15
CHRD common stock sold by Douglas Brooks
Restricted stock vesting 11/20/2020
1,678 shares
CHRD common stock vested as compensation from issuer
Restricted stock vesting 04/30/2026
2,039 shares
CHRD common stock vested as compensation from issuer
Key Terms
Form 144, Restricted Stock Vesting, Compensation, Common
4 terms
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Common | 11/20/2020 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Compensation financial
"11/20/2020 | Compensation Common | 08/01/2023"
Common financial
"Douglas Brooks 1001 Fannin Street Suite 1500 Houston TX 77002 | Common | 05/07/2026"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 144 filing by CHRD insider Douglas Brooks disclose?
The filing discloses that Douglas Brooks plans to sell up to 8,000 shares of CHRD common stock through Fidelity Brokerage Services, with an aggregate market value of $1,065,125.60 as of August 7, 2026.
What recent CHRD stock sales has Douglas Brooks reported before this Form 144?
Brooks reported selling 3,000 shares on May 7, 2026 for $413,378.95, 3,500 shares on May 8, 2026 for $478,482.50, and 1,500 shares on May 11, 2026 for $207,855.15, all in CHRD common stock.
On which market is Douglas Brooks’ CHRD Form 144 sale intended to occur?
The intended sale of up to 8,000 CHRD common shares is tied to trading on the NASDAQ, with an aggregate market value of $1,065,125.60 as of August 7, 2026, according to the filing details.
Which broker is handling Douglas Brooks’ planned CHRD stock sale under Form 144?
The planned sale of up to 8,000 CHRD shares is associated with Fidelity Brokerage Services LLC, listed with its Smithfield, Rhode Island address in the Form 144 securities information section.